NMC MED
ActiveSummary
NMC MED has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €121k and a net result of €62k. Equity is growing by ~26.4% per year across the filed fiscal years. Its solvency ranks better than 42% of 1246 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability98▼-2
Solvency71▲+24
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10k at 30 days acceptable
Liquidity ample (current ratio 1.95 against 1.21 in 2023; short-term debt: 29.6% and cash: 26.5% of total assets), but 54% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
60 d late
2023
61 d late
2022
25 d late
2021
25 d late
2020
31 d late
2019
118 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€62k▼ 35.1%
2023 · €95k
2019: €35k
2020: €-6k▼ -116% vs 2019lowest in 6 years
2021: €44k▲ +891% vs 2020
2022: €89k▲ +104% vs 2021
2023: €95k▲ +6.8% vs 2022highest in 6 years
2024: €62k▼ -35.1% vs 2023
2019 → 2024
Working capital
€74k▲ 182%
2023 · €26k
2019: €-160klowest in 6 years
2020: €30k▲ +119% vs 2019
2021: €40k▲ +31.7% vs 2020
2022: €126k▲ +218% vs 2021highest in 6 years
2023: €26k▼ -79.2% vs 2022
2024: €74k▲ +182% vs 2023
2019 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€32k-€55k▲ 73.9%€144k▲ 160%€59k▼ 59.0%€121k▲ 104%
2020: €32klowest in 5 years
2021: €55k▲ +73.9% vs 2020
2022: €144k▲ +160% vs 2021highest in 5 years
2023: €59k▼ -59.0% vs 2022
2024: €121k▲ +104% vs 2023
Operating result€-2k-€57k€121k▲ 111%€130k▲ 7.4%€88k▼ 32.3%
2020: €-2klowest in 5 years
2021: €57k▲ +2664% vs 2020
2022: €121k▲ +111% vs 2021
2023: €130k▲ +7.4% vs 2022highest in 5 years
2024: €88k▼ -32.3% vs 2023
Net result€-6k-€44k€89k▲ 104%€95k▲ 6.8%€62k▼ 35.1%
2020: €-6klowest in 5 years
2021: €44k▲ +891% vs 2020
2022: €89k▲ +104% vs 2021
2023: €95k▲ +6.8% vs 2022highest in 5 years
2024: €62k▼ -35.1% vs 2023
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 32% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €262k
Fixed assets
€111k ▼ 9.1%
Current assets
€151k ▲ 0.1%
Equity and liabilities €262k
Equity
€121k ▲ 104%
Debt
€141k ▼ 33.9%
Debt's share of the balance-sheet total falls from 78.3% to 54.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€113k▼
2023 · €152k
Cash flow
€86k▼
2023 · €117k
Current ratio
1.95▲
2023 · 1.21
Debt to equity
1.17▼
2023 · 3.62
ROE
51.0%▼
2023 · 160.6%
ROA
23.5%▼
2023 · 34.8%
Interest coverage
15.54▼
2023 · 28.08
Debt ≤ 1 year
€78k▼
2023 · €125k
Debt > 1 year
€64k▼
2023 · €89k
Income taxes
€19k▼
2023 · €32k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 47 lines
Balance sheet
Code20232024
Assets
Total assets20/58€273k€262k▼
Fixed assets21/28€122k€111k▼
Intangible fixed assets21€110k€88k▼
Tangible fixed assets22/27€12k€23k▲
Land and buildings22-€5k
Plant, machinery and equipment23€12k€10k▼
Furniture and vehicles24-€2k
Leasing and similar rights25-€5k
Financial fixed assets28€225€225=
Current assets29/58€151k€151k▲
Amounts receivable within one year40/41€104k€65k▼
Trade receivables40€104k€65k▼
Current investments50/53€2k€17k▲
Cash at bank and in hand54/58€43k€69k▲
Deferred charges and accrued income490/1€2k-
Equity and liabilities
Total equity and liabilities10/49€273k€262k▼
Equity10/15€59k€121k▲
Contributions10/11€3k€3k=
Reserves13€34k€34k=
Distributable reserves133€34k€34k=
Profit (loss) carried forward14€23k€84k▲
Amounts payable17/49€214k€141k▼
Amounts payable after more than one year17€89k€64k▼
Financial debts170/4€89k€64k▼
Amounts payable within one year42/48€125k€78k▼
Current portion of amounts payable after more than one year42€25k€25k▲
Trade debts44€3k€2k▼
Suppliers440/4€3k€2k▼
Taxes, remuneration and social security45€65k€31k▼
Taxes450/3€65k€31k▼
Other amounts payable47/48€32k€20k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€25k▲
Other operating charges640/8€483€575▲
Gross operating margin9900€152k€113k▼
Operating profit (loss)9901€130k€88k▼
Financial income75/76B€3k€15▼
Recurring financial income75€3k€15▼
Financial charges65/66B€5k€7k▲
Recurring financial charges65€5k€7k▲
Profit (loss) for the period before taxes9903€127k€80k▼
Income taxes67/77€32k€19k▼
Profit (loss) for the period9904€95k€62k▼
Profit (loss) for the period to be appropriated9905€95k€62k▼
Appropriation of the result
Profit (loss) to be appropriated9906€203k€84k▼
Profit (loss) brought forward from the previous period14P€108k€23k▼
Profit to be distributed694/7€180k-
Return on contributions (dividend)694€180k-
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €23k | €23k | €22k | €22k | €25k | ▲ 10.8% |
| Other operating charges640/8 | - | €348 | €146 | €483 | €575 | ▲ 19.1% |
| Gross operating margin9900 | €21k | €80k | €143k | €152k | €113k | ▼ 25.8% |
| Operating profit (loss)9901 | €-2k | €57k | €121k | €130k | €88k | ▼ 32.3% |
| Financial income75/76B | - | €86 | €1k | €3k | €15 | ▼ 99.5% |
| Recurring financial income75 | - | €86 | €1k | €3k | €15 | ▼ 99.5% |
| Financial charges65/66B | - | €7k | €5k | €5k | €7k | ▲ 33.8% |
| Recurring financial charges65 | €3k | €7k | €5k | €5k | €7k | ▲ 33.8% |
| Profit (loss) for the period before taxes9903 | €-5k | €51k | €117k | €127k | €80k | ▼ 36.6% |
| Income taxes67/77 | €350 | €7k | €28k | €32k | €19k | ▼ 41.0% |
| Profit (loss) for the period9904 | €-6k | €44k | €89k | €95k | €62k | ▼ 35.1% |
| Profit (loss) for the period to be appropriated9905 | €-6k | €44k | €89k | €95k | €62k | ▼ 35.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €337k | €242k | €297k | €273k | €262k | ▼ 4.0% |
| Fixed assets21/28 | €177k | €154k | €132k | €122k | €111k | ▼ 9.1% |
| Intangible fixed assets21 | €176k | €154k | €132k | €110k | €88k | ▼ 20.0% |
| Tangible fixed assets22/27 | €776 | - | - | €12k | €23k | ▲ 94.0% |
| Land and buildings22 | - | - | - | - | €5k | - |
| Plant, machinery and equipment23 | - | - | - | €12k | €10k | ▼ 10.4% |
| Furniture and vehicles24 | - | - | - | - | €2k | - |
| Leasing and similar rights25 | - | - | - | - | €5k | - |
| Financial fixed assets28 | - | €225 | €225 | €225 | €225 | = |
| Current assets29/58 | €160k | €88k | €165k | €151k | €151k | ▲ 0.1% |
| Amounts receivable within one year40/41 | €11k | €67k | €148k | €104k | €65k | ▼ 38.0% |
| Trade receivables40 | - | €50k | €80k | €104k | €65k | ▼ 38.0% |
| Other amounts receivable41 | - | €16k | €68k | - | - | - |
| Current investments50/53 | - | - | - | €2k | €17k | ▲ 1,050% |
| Cash at bank and in hand54/58 | €148k | €21k | €15k | €43k | €69k | ▲ 60.3% |
| Deferred charges and accrued income490/1 | - | €244 | €2k | €2k | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €337k | €242k | €297k | €273k | €262k | ▼ 4.0% |
| Equity10/15 | €32k | €55k | €144k | €59k | €121k | ▲ 104% |
| Contributions10/11 | - | €3k | €3k | €3k | €3k | = |
| Reserves13 | €34k | €34k | €34k | €34k | €34k | = |
| Distributable reserves133 | - | €34k | €34k | €34k | €34k | = |
| Profit (loss) carried forward14 | €-5k | €19k | €108k | €23k | €84k | ▲ 273% |
| Amounts payable17/49 | €305k | €187k | €153k | €214k | €141k | ▼ 33.9% |
| Amounts payable after more than one year17 | €175k | €138k | €114k | €89k | €64k | ▼ 28.2% |
| Financial debts170/4 | - | €138k | €114k | €89k | €64k | ▼ 28.2% |
| Amounts payable within one year42/48 | €130k | €48k | €39k | €125k | €78k | ▼ 37.9% |
| Current portion of amounts payable after more than one year42 | - | €24k | €25k | €25k | €25k | ▲ 0.9% |
| Trade debts44 | €4k | €1k | - | €3k | €2k | ▼ 38.6% |
| Suppliers440/4 | - | €1k | - | €3k | €2k | ▼ 38.6% |
| Taxes, remuneration and social security45 | - | €2k | €15k | €65k | €31k | ▼ 52.0% |
| Taxes450/3 | - | €2k | €15k | €65k | €31k | ▼ 52.0% |
| Other amounts payable47/48 | - | €20k | - | €32k | €20k | ▼ 39.6% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-6k | €44k | €89k | €95k | €62k | ▼ 35.1% |
| + Depreciation and write-downs630 | €23k | €23k | €22k | €22k | €25k | ▲ 10.8% |
| Operating cash flow (approximation) | €18k | €66k | €111k | €117k | €86k | ▼ 26.3% |
| Investment in fixed assets (approximation) | - | €-225 | €0 | €-12k | €-14k | ▼ 14.2% |
| Change in cash | - | €-127k | €-6k | €28k | €26k | ▼ 7.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2026
04-08
State Gazette act
Reappointments: Ramquet Caroline (director) and Marchant Nicolas (director)Director discharge5 facts ▸
State Gazette act
Reappointments: Ramquet Caroline (director) and Marchant Nicolas (director)
Director discharge5 facts ▸
- General meeting, 06/05/2025
- Director reappointment, Ramquet Caroline (director)
- Director reappointment, Marchant Nicolas (director)
- Director discharge, Ramquet Caroline
- Director discharge, Marchant Nicolas
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 60 days late
2024
31-12
Financial
Equity above €100kEq €121k ▲104%
4 profitable years in a row build equity to €121k.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 61 days late
2023
31-12
Financial
Highest result since 2019net €95k ▲6.8%
Operating result €130k, net result €95k, both a record.
25-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 25 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 4.19
Current ratio from 1.82 to 4.19; short-term debt falls from €48k to €39k.
31-12
Financial
Equity above €100kEq €144k ▲160%
2 profitable years in a row build equity to €144k.
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 25 days late
2021
31-12
Financial
Back to profitnet €44k
Net result €44k after one loss-making year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
2020
31-12
Financial
Weakest financial yearnet €-6k
Net result drops to €-6k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity times 5current ratio 1.23
Current ratio from 0.26 to 1.23; short-term debt falls from €216k to €130k.
26-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 118 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 2 acts read
About the unread acts
Of the 2 Belgian State Gazette acts we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 directors, last change in 2025
Marchant Nicolas
CurrentDirector · since 06-05-2025
Ramquet Caroline
CurrentDirector · since 06-05-2025
06-05-2025
Marchant Nicolas: Mandate renewed as Director
06-05-2025
Ramquet Caroline: Mandate renewed as Director
Not every act has been read: a resignation may be missing here
1 of this company's 2 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Nandrin · 2 establishment units since 2019
Ground area
4.7 ha
Building footprint
5,837 m²
Volume, LiDAR
1,234 m³
3 parcels, Wallonia · tallest building 9.6 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
2 establishment units
NMC MED
since 20192.323.168.806
NMC MED
since 20212.323.168.707
3 parcels
Wallonia
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52302A1075/00L005 | Wallonia | 2.6 ha | 1 · 4,980 m² | - |
| 61031C0328/00R000 | Wallonia | 1.9 ha | 1 · 692 m² | - |
| 61043C0156/00C000 | Wallonia | 1,495 m² | 1 · 164 m² | 9.6 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
RX DM
BE 0722.787.085
Dilbeek · Eq €120,728
Dr. David Degrauwe
BE 1000.983.184
Schoten · Eq €120,558
Docteurs LEROY-HIGUET
BE 0867.410.721
Nivelles · Eq €120,542
CASSIOPÉE MÉDICAL
BE 1007.608.383
Etterbeek · Eq €120,811
Dr. Isabelle Rooms, Dermatoloog
BE 0760.363.994
Aalter · Eq €120,495
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 6,550 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-05-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.